- Home
- ASND vs AR Comparison
ASND vs AR Comparison
Compare ASND & AR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- AR
- Stock Information
- Founded
- ASND 2006
- AR 2002
- Country
- ASND Denmark
- AR United States
- Employees
- ASND N/A
- AR N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- AR Oil & Gas Production
- Sector
- ASND Health Care
- AR Energy
- Exchange
- ASND Nasdaq
- AR Nasdaq
- Market Cap
- ASND 10.6B
- AR 12.5B
- IPO Year
- ASND 2015
- AR 2013
- Fundamental
- Price
- ASND $198.32
- AR $32.03
- Analyst Decision
- ASND Strong Buy
- AR Buy
- Analyst Count
- ASND 16
- AR 17
- Target Price
- ASND $239.50
- AR $43.38
- AVG Volume (30 Days)
- ASND 549.0K
- AR 5.4M
- Earning Date
- ASND 08-07-2025
- AR 07-30-2025
- Dividend Yield
- ASND N/A
- AR N/A
- EPS Growth
- ASND N/A
- AR 4491.03
- EPS
- ASND N/A
- AR 1.52
- Revenue
- ASND $576,332,355.00
- AR $4,870,111,000.00
- Revenue This Year
- ASND $79.35
- AR $29.51
- Revenue Next Year
- ASND $76.18
- AR $8.43
- P/E Ratio
- ASND N/A
- AR $21.09
- Revenue Growth
- ASND 54.50
- AR 11.79
- 52 Week Low
- ASND $111.09
- AR $24.53
- 52 Week High
- ASND $199.99
- AR $44.02
- Technical
- Relative Strength Index (RSI)
- ASND 69.11
- AR 34.32
- Support Level
- ASND $187.24
- AR $31.95
- Resistance Level
- ASND $197.67
- AR $33.13
- Average True Range (ATR)
- ASND 8.86
- AR 0.97
- MACD
- ASND 1.92
- AR 0.07
- Stochastic Oscillator
- ASND 95.73
- AR 2.37
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About AR Antero Resources Corporation
Antero Resources, based in Denver, engages in the exploration for and production of natural gas and natural gas liquids in the United States and Canada. At the end of 2024, the company reported proven reserves of 17.9 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,424 million cubic feet of equivalent a day in 2024 at a ratio of 35% liquids and 65% natural gas.